SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-21-022813
Filing Date
2021-04-26
Accepted
2021-04-26 09:00:19
Documents
4
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea139861-def14a_inmunebio.htm DEF 14A 533785
2 GRAPHIC image_001.jpg GRAPHIC 10513
3 GRAPHIC proxy_001.jpg GRAPHIC 143555
4 GRAPHIC proxy_002.jpg GRAPHIC 128939
  Complete submission text file 0001213900-21-022813.txt   924934
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38793 | Film No.: 21851876
SIC: 2836 Biological Products, (No Diagnostic Substances)